For citations:
Leontyev D.S., Urusov F.A., Glazkova D.V., Belugin B.V., Orlova O.V., Mintaev R.R., Tsyganova G.M., Bogoslovskaya E.V., Shipulin G.A. Study of the protective efficacy of CombiMab-2 against human immunodeficiency virus type 1 in mice humanised with CD4+ T-lymphocytes. Biological Products. Prevention, Diagnosis, Treatment. 2024;24(3):312-321. (In Russ.) https://doi.org/10.30895/2221-996X-2024-24-3-312-321
Email this article 